Persistent URL of this record https://hdl.handle.net/1887/101707
In Collections
This item can be found in the following collections:
EFFICACY AND SAFETY OF TABALUMAB, AN ANTI-B CELL ACTIVATING FACTOR MONOCLONAL ANTIBODY, IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO HAD AN INADEQUATE RESPONSE TO TNF-ALPHA INHIBITORS: RESULTS FROM A PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND STUDY
- All authors
- Schiff, M.; Combe, B.; Dorner, T.; Kremer, J.M.; Huizinga, T.W.; Veenhuizen, M.; Gill, A.; Zou, H.; Komocsar, W.; Berclaz, P.Y.; Ortmann, R.; Lee, C.
- Date
- 2014-06-30
- Journal
- Annals of the Rheumatic Diseases
- Volume
- 73
- Pages
- 952 - 953